SALLA TREATMENT AND RESEARCH FOUNDATION INC (EIN 825186436) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Principal Officer

JESSICA KLEIN FOGLIO

Phone

7273485184

Tax Period

2024-01-01 to 2024-12-31

SALLA TREATMENT AND RESEARCH FOUNDATION INC, founded in 2018, is a small nonprofit in the Diseases & Disorders sector that reported $234K in total revenue in fiscal year 2024. Revenue grew 9% year-over-year, indicating healthy expansion. The organization ran a surplus of $82K, a strong 35% operating margin.

Mission

TO SUPPORT AND ADVANCE SALLA DISEASE TREATMENTS, RESEARCH, EDUCATION, AWARENESS, AND FAMILY NETWORKS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $233,725

Program Service Revenue $0

Investment Income $146

Other Revenue $0

TOTAL REVENUE $233,871

Expense Breakdown

Grants Paid $111,383

Salaries & Benefits $0

Fundraising Expenses $7,246

Program Expenses $113,483

Other Expenses $40,160

TOTAL EXPENSES $151,543

Year-over-Year Comparison

	2024	2023	Change
Revenue	$233,871	$214,738	+0.1%
Expenses	$151,543	$125,940	+0.2%
Net Income	$82,328	$88,798	-0.1%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ADAM LEBLANC	BOARD MEMEBER	2.00	Director	$0	$0	$0
KATHRINE ROA	BOARD MEMBER	2.00	Director	$0	$0	$0
JESSICA KLEIN FOGLIO	PRESIDENT	15.00	Officer Director	$0	$0	$0
MICHAEL FOGLIO	VICE PRESIDENT	5.00	Officer Director	$0	$0	$0
DAVID HALPERN	SECRETARY	2.00	Officer Director	$0	$0	$0
KENNETH KLEIN	TREASURER	5.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$233,871	$151,543	$258,554	$82,328
2023	$214,738	$125,940	$176,226	$88,798
2022	$66,946	$125,034	$68,023	$-58,088
2021	$82,490	$112,617	$95,141	$-30,127
2020	$120,626	$114,423	$125,268	$6,203

SALLA TREATMENT AND RESEARCH FOUNDATION INC